Open AccessChronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings)
Author(s) -
V. А. Parfenov,
С. А. Живолупов,
Zakharov Vv,
Л. А. Белова,
О.В. Лагода,
Р. Г. Есин,
Н. В. Вахнина,
И. Н. Самарцев
Publication year - 2018
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2018-4-139-145
Subject(s) - vinpocetine , medicine , disease , intensive care medicine , encephalopathy , pediatrics , pharmacology
The paper presents the proceedings of the Round Table with the participation of leading neurologists, which is devoted to chronic cerebrovascular diseases. It is noted that chronic cerebral ischemia (CCI), or dyscirculatory encephalopathy (DEP), is one of the most common neurological diagnoses in our country. The pathogenesis, clinical presentations, diagnosis and treatment of CCI (DEP) and its matching with vascular cognitive impairment (CI), which is regarded in foreign literature as the main manifestation of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating the efficacy of vinpocetine (Cavinton) in chronic CVD, dizziness, CI, as well as the use of new vinpocetine formulations, such as Cavinton Comforte, in various neurological diseases, dysphagia in particular, in poststroke patients.